|
|
Article: China Biologic Products Appoints Director of Research and Development.
- Article from:
- PR Newswire
- Article date:
- September 9, 2009
CopyrightCOPYRIGHT 2009 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
TAI'AN, China, Sept. 9 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (BULLETIN BOARD: CBPO) ("China Biologic," or the "Company"), one of the leading plasma-based pharmaceutical companies in the People's Republic of China ("PRC"), operating through its indirect majority-owned subsidiaries, Shandong Taibang Biological Products Co. Ltd. ("Taibang") and Chongqing Dalin Biologic Technologies Co., Ltd. ("Dalin") and its equity investment in Xi'an Huitian Blood Products Co., Ltd. ("Huitian"), today announced that the Company has appointed Dr. Vincent Yi-Wu Xie to be the Company's Director of Research and Development, effective September 1, 2009, to oversee the ...
Related newspaper, magazine, and journal articles:
|
|
Article: China Biologic Products to Present at CCG ...
PR Newswire;
May 15, 2009 ;
700+ words
... ... PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (BULLETIN BOARD: CBPO ... institutional sales representative. About China Biologic Products, Inc. China Biologic Products, Inc. (the ''Company''), through ...
|
|